Lung cancer diagnosis marker and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 天津脉络医学检验有限公司
- Publication Date
- 2018-03-09
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedical detection, and relates to a marker for lung cancer diagnosis and its application, in particular to a marker UHRF1 gene for lung cancer diagnosis and its application. Background technique
[0002] Epidemiology points out that lung cancer is one of the malignant tumors with the fastest-growing morbidity and mortality. Among the causes of cancer-related deaths in the world, lung cancer ranks first. Non-small cell lung cancer (NSCLC) accounts for about 85% of all diagnosed primary lung cancers, and small cell lung cancer (SCLC) accounts for about 20%-25% of lung cancers. In recent years, scientific researchers have paid more and more attention to the study of tumor molecular biology, and found many tumor markers that can indicate the source and histological type of tumors. The detection of tumor markers has important clinical value in the screening, diagnosis, curative effect detection and prognos...